Search the LHSFNA website
Published: December, 2018; Vol 15, Num 6

 

Health & Safety Headlines

OSHA National Emphasis on Trench Fatalities

In response to a spike in trench fatalities, OSHA is increasing education and enforcement efforts and inspecting more trenches and excavations across the U.S. The emphasis program began on October 1st with a three-month period of education and outreach. Additional enforcement for all trenches and excavations is due to start in January and will continue until further notice.

NIOSH Releases Naloxone Fact Sheet

The National Institute for Occupational Safety and Health has released a new fact sheet aimed at helping employers decide if their workplace should make use of the overdose-reversal medication also known as Narcan. The LHSFNA wrote more about this topic in our October 2018 issue.

OSHA Clarifies on Incentive Programs and Post-Incident Drug Testing

In a recent memo, OSHA clarified that a previous rule issued in 2016 did not disallow safety incentive programs or post-incident drug testing. The memo details why post-incident drug testing after a work-related injury or illness does not qualify as retaliation. Similarly, an employee losing out on a prize in an incentive program would not be a deterrent to reporting if other adequate precautions are in place to ensure employees feel free to report injury or illness.

FDA Approves New Powerful Opioid

The Food and Drug Administration has approved Dsuvia, an opioid tablet that is 1,000 times stronger than morphine and 10 times stronger than fentanyl. Its use is restricted to health care settings such as surgery centers and emergency rooms, and the drug will not be available at retail pharmacies. The medication, which comes in a single-use package, should not be used for more than 72 hours.